Agreement on Major Pathological Response in NSCLC Patients Receiving Neoadjuvant Chemotherapy
Clinical Lung Cancer - United States
doi 10.1016/j.cllc.2019.11.003
Full Text
Open PDFAbstract
Available in full text
Date
March 1, 2020
Authors
Publisher
Elsevier BV